Cargando…
Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy
BACKGROUND: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs. MATERIALS & METHODS: This retrospective study included 215 patients with metastatic malig...
Autores principales: | Assi, Hussein A, Asch, Adam S, Machiorlatti, Michael, Vesely, Sara K, Ibrahimi, Sami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421541/ https://www.ncbi.nlm.nih.gov/pubmed/32802390 http://dx.doi.org/10.2144/fsoa-2020-0021 |
Ejemplares similares
-
Disparity in outcomes of melanoma adjuvant immunotherapy by demographic profile
por: Ikeguchi, Alexandra, et al.
Publicado: (2020) -
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy
por: Eoli, Marica, et al.
Publicado: (2019) -
Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag
por: Tarantino, Michael D., et al.
Publicado: (2014) -
Development and Validation Nomogram for Predicting the Survival of Patients with Thrombocytopenia in Intensive Care Units
por: Jiang, Zhen-Hong, et al.
Publicado: (2023) -
Factors associated with meeting physical activity guidelines during the COVID-19 pandemic
por: Heredia, Natalia I., et al.
Publicado: (2022)